Follow The Filings

CABA Cabaletta Bio

Cabaletta Bio earnings company data as of 4:47 AM ET 10/22

  • 1 of 1 EPS beats

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS -0.34 -0.34 Beat
Rev — — —

Insider trades

Open-market buys and sales by CABA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CABA insider trades
  • $296K bought by 8 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. David J. Chang Chief Medical Officer
    Buy
    $20K 8,800 shares at $2.26 New stake
    Traded Jan 21 Filed Jan 21
    ↗
  2. Gwendolyn Binder President, Science & Tech.
    Buy
    $25K 11,312 shares at $2.19 +57% to stake
    Traded Jan 21 Filed Jan 21
    ↗
  3. Shawn Tomasello Director
    Buy
    $50K 22,725 shares at $2.21 New stake
    Traded Jan 21 Filed Jan 21
    ↗
  4. Steve Gavel Chief Commercial Officer
    Buy
    $50K 22,170 shares at $2.27 New stake
    Traded Jan 21 Filed Jan 21
    ↗
  5. Catherine Bollard Director
    Buy
    $9,982 4,405 shares at $2.27 +441% to stake
    Traded Jan 21 Filed Jan 21
    ↗
  6. Steven Nichtberger CEO
    Buy
    $101K 45,000 shares at $2.24 +4.6% to stake
    Traded Jan 21 Filed Jan 21
    ↗
  7. Mark Simon Director
    Buy
    $25K 11,061 shares at $2.28 +8.1% to stake
    Traded Jan 21 Filed Jan 21
    ↗
  8. Michael Gerard General Counsel
    Buy
    $15K 6,600 shares at $2.27 New stake
    Traded Jan 21 Filed Jan 21
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,2.02,8.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.